118 related articles for article (PubMed ID: 25591911)
21. Surface Toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness.
Bugge M; Bergstrom B; Eide OK; Solli H; Kjønstad IF; Stenvik J; Espevik T; Nilsen NJ
J Biol Chem; 2017 Sep; 292(37):15408-15425. PubMed ID: 28717003
[TBL] [Abstract][Full Text] [Related]
22. TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin.
Park SJ; Lee AN; Youn HS
Arch Pharm Res; 2010 Jun; 33(6):939-45. PubMed ID: 20607500
[TBL] [Abstract][Full Text] [Related]
23. Chloroquine attenuates TLR3/IFN-β signaling in cultured normal human mesangial cells: A possible protective effect against renal damage in lupus nephritis.
Imaizumi T; Hayakari R; Matsumiya T; Yoshida H; Tsuruga K; Watanabe S; Kawaguchi S; Tanaka H
Mod Rheumatol; 2017 Nov; 27(6):1004-1009. PubMed ID: 28150518
[TBL] [Abstract][Full Text] [Related]
24. Synergistic expression of the CXCL10 gene in response to IL-1β and IFN-γ involves NF-κB, phosphorylation of STAT1 at Tyr701, and acetylation of histones H3 and H4.
Burke SJ; Goff MR; Lu D; Proud D; Karlstad MD; Collier JJ
J Immunol; 2013 Jul; 191(1):323-36. PubMed ID: 23740952
[TBL] [Abstract][Full Text] [Related]
25. Temporally designed treatment of melanoma cells by ATRA and polyI: C results in enhanced chemokine and IFNβ secretion controlled differently by TLR3 and MDA5.
Szabo A; Osman RM; Bacskai I; Kumar BV; Agod Z; Lanyi A; Gogolak P; Rajnavolgyi E
Melanoma Res; 2012 Oct; 22(5):351-61. PubMed ID: 22797253
[TBL] [Abstract][Full Text] [Related]
26. Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells.
Buttmann M; Berberich-Siebelt F; Serfling E; Rieckmann P
J Vasc Res; 2007; 44(1):51-60. PubMed ID: 17167270
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional and epigenetic modulation of human rhinovirus-induced CXCL10 production by cigarette smoke.
Hudy MH; Traves SL; Proud D
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):571-82. PubMed ID: 24127910
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor 3 signaling contributes to the expression of a neutrophil chemoattractant, CXCL1 in human mesangial cells.
Imaizumi T; Aizawa T; Segawa C; Shimada M; Tsuruga K; Kawaguchi S; Matsumiya T; Yoshida H; Joh K; Tanaka H
Clin Exp Nephrol; 2015 Oct; 19(5):761-70. PubMed ID: 25471749
[TBL] [Abstract][Full Text] [Related]
29. Desferrioxamine, an iron chelator, enhances HIF-1alpha accumulation via cyclooxygenase-2 signaling pathway.
Woo KJ; Lee TJ; Park JW; Kwon TK
Biochem Biophys Res Commun; 2006 Apr; 343(1):8-14. PubMed ID: 16527254
[TBL] [Abstract][Full Text] [Related]
30. Examination of a Viral Infection Mimetic Model in Human iPS Cell-Derived Insulin-Producing Cells and the Anti-Apoptotic Effect of GLP-1 Analogue.
Baden MY; Fukui K; Hosokawa Y; Iwahashi H; Imagawa A; Shimomura I
PLoS One; 2015; 10(12):e0144606. PubMed ID: 26659307
[TBL] [Abstract][Full Text] [Related]
31. Role of MDA5 in regulating CXCL10 expression induced by TLR3 signaling in human rheumatoid fibroblast-like synoviocytes.
Saruga T; Imaizumi T; Kawaguchi S; Seya K; Matsumiya T; Sasaki E; Sasaki N; Uesato R; Ishibashi Y
Mol Biol Rep; 2021 Jan; 48(1):425-433. PubMed ID: 33387195
[TBL] [Abstract][Full Text] [Related]
32. Stat1 required for interferon-inducible but not constitutive responsiveness to extracellular dsRNA.
Elco CP; Sen GC
J Interferon Cytokine Res; 2007 May; 27(5):411-24. PubMed ID: 17523873
[TBL] [Abstract][Full Text] [Related]
33. Interferon (IFN)-Induced Protein 35 (IFI35), a Type I Interferon-Dependent Transcript, Upregulates Inflammatory Signaling Pathways by Activating Toll-Like Receptor 3 in Human Mesangial Cells.
Imaizumi T; Yano C; Numata A; Tsugawa K; Hayakari R; Matsumiya T; Yoshida H; Watanabe S; Tsuruga K; Kawaguchi S; Murakami M; Tanaka H
Kidney Blood Press Res; 2016; 41(5):635-642. PubMed ID: 27639618
[TBL] [Abstract][Full Text] [Related]
34. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction.
Dong LW; Kong XN; Yan HX; Yu LX; Chen L; Yang W; Liu Q; Huang DD; Wu MC; Wang HY
Mol Immunol; 2008 Jun; 45(11):3025-35. PubMed ID: 18471880
[TBL] [Abstract][Full Text] [Related]
35. Elucidation of the inhibitory effect of (+)-hopeaphenol on polyinosinic-polycytidylic acid-induced innate immunity activation in human cerebral microvascular endothelial cells.
Xu L; Yu Z; Uekusa Y; Kawaguchi S; Kikuchi H; Daitoku K; Minakawa M; Motomura S; Furukawa KI; Oshima Y; Seya K; Imaizumi T
J Pharmacol Sci; 2022 Jul; 149(3):147-157. PubMed ID: 35641027
[TBL] [Abstract][Full Text] [Related]
36. Differential responsiveness to IFN-alpha and IFN-beta of human mature DC through modulation of IFNAR expression.
Severa M; Remoli ME; Giacomini E; Ragimbeau J; Lande R; Uzé G; Pellegrini S; Coccia EM
J Leukoc Biol; 2006 Jun; 79(6):1286-94. PubMed ID: 16624932
[TBL] [Abstract][Full Text] [Related]
37. Cepharanthine Inhibits IFN-γ-Induced CXCL10 by Suppressing the JAK2/STAT1 Signal Pathway in Human Salivary Gland Ductal Cells.
Aota K; Yamanoi T; Kani K; Azuma M
Inflammation; 2018 Feb; 41(1):50-58. PubMed ID: 28879548
[TBL] [Abstract][Full Text] [Related]
38. Heparins modulate the IFN-γ-induced production of chemokines in human breast cancer cells.
Fluhr H; Seitz T; Zygmunt M
Breast Cancer Res Treat; 2013 Jan; 137(1):109-18. PubMed ID: 23160925
[TBL] [Abstract][Full Text] [Related]
39. Cylindromatosis (CYLD), a Deubiquitinase, Attenuates Inflammatory Signaling Pathways by Activating Toll-Like Receptor 3 in Human Mesangial Cells.
Imaizumi T; Hayakari R; Watanabe S; Aizawa T; Matsumiya T; Yoshida H; Tsuruga K; Kawaguchi S; Tanaka H
Kidney Blood Press Res; 2017; 42(5):942-950. PubMed ID: 29166644
[TBL] [Abstract][Full Text] [Related]
40. Glomerular expression of fractalkine is induced by polyinosinic-polycytidylic acid in human mesangial cells: possible involvement of fractalkine after viral infection.
Aizawa-Yashiro T; Imaizumi T; Tsuruga K; Watanabe S; Matsumiya T; Hayakari R; Yoshida H; Satoh K; Ito E; Tanaka H
Pediatr Res; 2013 Feb; 73(2):180-6. PubMed ID: 23168573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
